Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors.

2014

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

30

References

40

Citations